Abstract:Porcine Rotavirus (PoRV) is a significant pathogen affecting swine-rearing regions globally, presenting a substantial threat to the economic development of the livestock sector. At present, no specific pharmaceuticals are available for this disease, and treatment options remain exceedingly limited. This study seeks to design a multi-epitope peptide vaccine for PoRV employing bioinformatics approaches to robustly activate T-cell and B-cell immune responses. Two antigenic proteins, VP7 and VP8*, were selected from PoRV, and potential immunogenic T-cell and B-cell epitopes were predicted using immunoinformatic tools. These epitopes were further screened according to non-toxicity, antigenicity, non-allergenicity, and immunogenicity criteria. The selected epitopes were linked with linkers to form a novel multi-epitope vaccine construct, with the PADRE sequence (AKFVAAWTLKAAA) and RS09 peptide attached at the N-terminus of the designed peptide chain to enhance the vaccine's antigenicity. Protein-protein docking of the vaccine constructs with toll-like receptors (TLR3 and TLR4) was conducted using computational methods, with the lowest energy docking results selected as the optimal predictive model. Subsequently, molecular dynamics (MD) simulation methods were employed to assess the stability of the protein vaccine constructs and TLR3 and TLR4 receptors. The results indicated that the vaccine-TLR3 and vaccine-TLR4 docking models remained stable throughout the simulation period. Additionally, the C-IMMSIM tool was utilized to determine the immunogenic triggering capability of the vaccine protein, demonstrating that the constructed vaccine protein could induce both cell-mediated and humoral immune responses, thereby playing a role in eliciting host immune responses. In conclusion, this study successfully constructed a multi-epitope vaccine against PoRV and validated the stability and efficacy of the vaccine through computational analysis. However, as the study is purely computational, experimental evaluation is required to validate the safety and immunogenicity of the newly constructed vaccine protein.

Construction of an artificial recombinant bicistronic plasmid DNA vaccine against porcine rotavirus

Directed chromosomal integration and expression of porcine rotavirus outer capsid protein VP4 in Lactobacillus casei ATCC393

Directed chromosomal integration and expression of porcine rotavirus outer capsid protein VP 4 in Lactobacillus casei ATCC393

Surface Display of Antigen Protein VP8* of Porcine Rotavirus on Bacillus Subtilis Spores Using CotB as a Fusion Partner

Evaluation of the immunogenicity of auxotrophic Lactobacillus with CRISPR-Cas9D10A system-mediated chromosomal editing to express porcine rotavirus capsid protein VP4

Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice

Oral Vaccination with the Porcine Rotavirus VP4 Outer Capsid Protein Expressed Bylactococcus Lactisinduces Specific Antibody Production

Auxotrophic Lactobacillus Expressing Porcine Rotavirus VP4 Constructed Using CRISPR-Cas9D10A System Induces Effective Immunity in Mice

Auxotrophic <i>Lactobacillus</i> Expressing Porcine Rotavirus VP4 Constructed Using CRISPR-Cas9D10A System Induces Effective Immunity in Mice

Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.

Virus-like Particles vaccine based on co-expression of G5 Porcine rotavirus VP2-VP6-VP7 induces a powerful immune protective response in mice

Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing S gene from porcine epidemic diarrhea virus and VP7 gene from porcine rotavirus

Recombinant Lactobacillus plantarum NC8 strain expressing porcine rotavirus VP7 induces specific antibodies in BALB/c mice

Construction of porcine circovirus type 2 ORF1 and ORF2 fusion genes eukaryotic expression vector and its immunological properties in mice

Construction and Identification of a Recombinant Attenuated Salmonella Expressing Streptococcus suis sly Gene

Design of multi-epitope vaccine against porcine rotavirus using computational biology and molecular dynamics simulation approaches

Construction and expression of virus-like particles containing rotavirus NSP3gene

Construction and expression of a recombinant plasmid containing the porcine epidemic diarrhea virus S1 gene delivered by Lactobacillus

The synergy of recombinant NSP4 and VP4 from porcine rotavirus elicited a strong mucosal response

Primary Studies on DNA Immunization of Human Rotavirus

Construction of the Eukaryotic Expression Plasmid with PPV VP2 Gene and PCV2 ORF2 Antigen Predominance Region Gene and Study on Immunogenicity of the Plasmid